Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.833 USD | +0.34% | -2.15% | -59.30% |
Apr. 16 | Scilex Issues Preliminary Q1 Sales Results for ZTlido | MT |
Mar. 20 | Scilex Seeks FDA Approval to Add Dosing Guidance to Gout Treatment Drug Label | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.30% | 101M | |
+7.63% | 72.94B | |
+12.64% | 9.06B | |
-10.56% | 5.07B | |
+58.79% | 4.78B | |
+4.07% | 3.9B | |
-16.90% | 2.56B | |
+21.52% | 2.42B | |
-26.13% | 2.39B | |
+19.31% | 2.18B |
- Stock Market
- Equities
- SCLX Stock
- News Scilex Holding Company
- Scilex Seeks FDA Approval to Add Dosing Guidance to Gout Treatment Drug Label